Webinar: Precision Matters — Optimizing PCI Through Robotics

Part of the Diagnostic and Interventional Cardiology Webinar Series — supported by an educational grant from Philips Healthcare

 

September 4, 2013
John Jeffrey Marshall, M.D., FACC, FSCAI

This webinar will focus on how robotic-assistance can serve to optimize percutaneous coronary interventions (PCI). This talk will explain the value of robotic-assistance in the cath lab, which includes the potential to reduce stent utilization, minimize longitudinal geographic miss and reduce radiation to the physician.

Archived Webinar:  CME not available for on-demand session.

Originally broadcast on Wednesday, September 9, 2013

To view on-demand, click here

Statement of Purpose/Need:
New technology such as robotic-assistance can serve to optimize PCI. This talk will explain the value of robotic-assistance in the cath lab, which includes the potential to reduce stent utilization, minimize longitudinal geographic miss and reduce radiation to the physician.

Upon completion of this activity, participants will be able to:

  1. Summarize the challenges that limit optimized results in PCI
  2. Describe how robotics have the potential to improve patient outcomes
  3. Explain how robotics can reduce stent utilization through precise device control
  4. Define how robotics can increase physician safety in the cath lab
  5. Employ robotics to enhance procedural accuracy in coronary artery catheter based interventions

 

Presenter:

John Jeffrey Marshall, M.D., FACC, FSCAI

Medical Director of the Cardiac Catheterization Laboratory at Northeast Georgia Medical Center
Medical Director of the Northeast Georgia Medical Center Research Committee
Serves on the Subspecialty Board on Cardiovascular Disease for the American Board of Internal Medicine
Board certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology.

Intended Audience:
This webinar is intended for interventional cardiologists, cath lab administrators and cath lab staff

Accreditation and Credit Designation:
This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Academy for Continued Healthcare Learning (ACHL) and Scranton Gillette Communications. ACHL is accredited by the ACCME to provide continuing medical education for physicians.

The Academy for Continued Healthcare Learning designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure information:
Current guidelines require that participants in CME/CE activities be made aware of all affiliations or financial interests that may be perceived as affecting the presentation of the faculty member. All conflicts of interest will be resolved prior to the start of the educational activity.

John Jeffrey Marshall, M.D., FACC, FSCAI
Medical Director of the Cardiac Catheterization Laboratory at NGMC
Medical Director of the NGHC Research Committee
Serves on the Subspecialty Board on Cardiovascular Disease for the American Board of Internal Medicine
Board certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology

Research Support:
Corindus, Abbott Vascular, Medtronic, St. Jude, NIH (National Institutes of Health)

Discussion of off-label, investigational or experimental drug use: None

The Academy for Continued Healthcare Learning and Scranton Gillette Communications staff members and others involved with the planning, development and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Copyright and Policy of Privacy, click Here

To test if your computer meets the hardware/software requirements to view this webcast, please click on the HELP tab above and run the SYSTEM TEST. If you have any technical questions please click on the HELP tab above.
 
To view on-demand, click Here